Literature DB >> 8948295

Natural remission in inflammatory polyarthritis: issues of definition and prediction.

B J Harrison1, D P Symmons, P Brennan, E M Barrett, A J Silman.   

Abstract

This paper reports the frequency and predictors of remission (no arthritis on examination and no treatment with second-line drugs or steroids within the previous 3 months) in 358 patients with early inflammatory polyarthritis (IP) referred to the Norfolk Arthritis Register. Two years after referral, 91 patients (25%) were in remission, 32 of whom had also been in remission at 1 yr. Remission rates were twice as high in patients with undifferentiated inflammatory polyarthritis at baseline as in those who satisfied criteria for rheumatoid arthritis. To identify predictors of remission, a logistic regression model was developed on a random two-thirds of the patients and validated on the remaining one-third. Remission at 2 yr was associated with male gender and fewer than six tender joints at baseline. However, even the best-fitting model was not sensitive enough to be useful clinically. Thus, amongst patients with early IP in the community, remission rates at 2 yr are low. Further, it was impossible, using simple clinical measures, to predict those patients whose arthritis would resolve.

Entities:  

Mesh:

Year:  1996        PMID: 8948295     DOI: 10.1093/rheumatology/35.11.1096

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  29 in total

1.  Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.

Authors:  C H van Jaarsveld; J W Jacobs; M J van der Veen; A A Blaauw; A A Kruize; D M Hofman; H L Brus; G A van Albada-Kuipers; A H Heurkens; E J ter Borg; H C Haanen; C van Booma-Frankfort; Y Schenk; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

3.  Patients with rheumatoid arthritis in clinical care.

Authors:  J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

4.  Early treatment of rheumatoid arthritis: rationale, evidence, and implications.

Authors:  L B van de Putte; A M van Gestel; P L van Riel
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

Review 5.  The epidemiology of early inflammatory arthritis.

Authors:  Johanna M W Hazes; Jolanda J Luime
Journal:  Nat Rev Rheumatol       Date:  2011-06-14       Impact factor: 20.543

6.  Clinical features and independent predictors in the further development of rheumatoid arthritis in undifferentiated arthritis.

Authors:  Dongying Chen; Hao Li; Liuqin Liang; Youjun Xiao; Ting Xu; Qian Qiu; Fan Lian; Zhongping Zhan; Yujin Ye; Hanshi Xu; Xiuyan Yang
Journal:  Rheumatol Int       Date:  2013-07-09       Impact factor: 2.631

7.  Predictive factors related to progression toward rheumatoid arthritis in Korean patients with undifferentiated arthritis.

Authors:  You Jung Ha; Yong-Beom Park; Myoung-Kyun Son; Sang-Youn Jung; Kwang-Hoon Lee; Soo-Kon Lee
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

8.  Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study.

Authors:  L Gossec; M Dougados; P Goupille; A Cantagrel; J Sibilia; O Meyer; J Sany; J-P Daurès; B Combe
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

9.  Very recent onset arthritis: the value of initial rheumatologist evaluation and anti-cyclic citrullinated peptide antibodies in the diagnosis of rheumatoid arthritis.

Authors:  Jorge Rojas-Serrano; Rubén Burgos-Vargas; Leticia Lino Pérez; Conrado García García; Francisco Moctezuma; Janitzia Vázquez-Mellado
Journal:  Clin Rheumatol       Date:  2009-06-07       Impact factor: 2.980

10.  The prognostic value of baseline erosions in undifferentiated arthritis.

Authors:  Mohamed M Thabet; Thomas W J Huizinga; Désirée M van der Heijde; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2009-10-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.